Delivery Order SPE2DB22D2007-SPE2DB24FH9MN

Award Date 2/12/24
Potential Completion Date 3/5/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the pharmaceutical drug BENLYSTA. The order has a completion date of March 18, 2024 and a potential value of $1,259.50. Amerisourcebergen Drug Corp is a prime contractor for DLA, providing a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities....
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, is a delivery order valued at $13,854.50 for the supply of 400 mg vials of the medication BENLYSTA. The award was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract does not have a set-aside designation and is a firm fixed price delivery order with an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp is...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 400 mg vials of the specialty pharmaceutical drug BENLYSTA. The $1,259.50 contract has a completion date of February 26, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under an indefinite delivery contract (IDC) with a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,259.50 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide BENLYSTA 400 mg vials. The contract has a completion date of February 27, 2024. This delivery order is part of Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,259.50 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BENLYSTA 400 MG vials. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA...
This is a $5,038.00 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 400 MG VIALS. The award has an ultimate completion date of October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,606.06 firm fixed-price delivery order is for the supply of BENLYSTA 400 MG VIALS, a specialty medication. The contract has an ultimate completion date of January 16, 2025 and was awarded on December 24, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 400 mg vials of the pharmaceutical product BENLYSTA. The delivery order, valued at $1,259.50, has a completion date of March 19, 2024 and was awarded on February 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00, through December 31, 2025, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,076.40 firm fixed-price contract is for the supply of BENLYSTA 200 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of April 15, 2025 and was awarded on March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $7,557 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for the supply of 400 mg vials of the prescription drug BENLYSTA. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies from AmerisourceBergen to...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FH9MN
    Delivery Order

This contract is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution subsidiary of Amerisourcebergen Corporation. The $1,259.50 firm fixed price award is for the supply of 400 mg vials of the specialty medication BENLYSTA, with a completion date of March 5, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing, single-award indefinite delivery contract (IDC) with DLA, which has a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC enables Amerisourcebergen to provide a wide range of pharmaceutical products and medical supplies to support DLA's Troop Support Medical programs and military treatment facilities. No small business set-aside designation was used for this specific order.

Generated 5/13/24, 9:45 AM